A group of 21 patients with malignant pleural effusions were treated with the instillation of 40 mg mitoxantrone intrapleurally, after complete fluid drainage. There was a 100% complete response rate with no toxic effects (0%). The mean survival of the patients was 57.1 weeks.
β¦ LIBER β¦
Thoracoscopic palliative treatment of malignant pleural effusions
β Scribed by K. Arapis; R. Caliandro; J-B. Stern; P. Girard; D. Debrosse; D. Gossot
- Book ID
- 106153922
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 111 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0930-2794
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Intrapleural mitoxantrone for the pallia
β
Manuel Morales; Maria del Carmen ExpΓ³sito
π
Article
π
1995
π
Springer-Verlag
π
English
β 230 KB
The treatment of malignant pleural effus
β
Dr. Charles B. Anderson; Gordon W. Philpott; Thomas B. Ferguson
π
Article
π
1974
π
John Wiley and Sons
π
English
β 553 KB
Suitable device for thoracoscopic talc p
β
Andrea Billè; Piero Borasio; Mara Gisabella; Luca Errico; Robert Gatherer; Franc
π
Article
π
2011
π
Springer Japan
π
Japanese
β 261 KB
Management of malignant pleural effusion
β
Y. C. Gary LEE; Richard W. LIGHT
π
Article
π
2004
π
John Wiley and Sons
π
English
β 161 KB
BCG treatment of malignant pleural effus
β
Pimm, M V; Hopper, D G; Baldwin, R W
π
Article
π
1976
π
Nature Publishing Group
π
English
β 651 KB
Management of malignant pleural effusion
β
David W. Greenwald; Clay Phillips; John M. Bennett
π
Article
π
1978
π
John Wiley and Sons
π
English
β 428 KB
## Abstract A pleural effusion is a frequent complication of malignant disease. Essential to the care of oncology patients is a fundamental knowledge of the pathophysiology and treatment of such effusions. This article discusses the current thoughts concerning the occurrence of malignant effusions,